Marina Urena
Marina Urena is an expert in Cardiology at Hôpital Bichat-Claude-Bernard (France). As of October 2026, ScienceLeadR ranks Marina Urena in the top 1% of experts worldwide for Aortic Valve Disease. Marina Urena has authored 293 publications, the most recent in 2026, and is an investigator in 14 clinical trials, 3 of them ongoing. SLR score: 1,200 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Thoracic And Cardiovascular Surgery - Surgery - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2011 - 2026
Number : 293
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Early changes in pulmonary arterial systolic pressure after transcatheter edge-to-edge mitral valve repair and their association with outcomes. PMID 42660223 — mitral valve, cardiovascular diseases, echocardiography, mitral valve insufficiency | Rev Esp Cardiol (Engl Ed) | 2026 | 0 |
| Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement. PMID 42635326 — mortality, cardiovascular surgical procedures, stroke, incidence, heart failure, aortic valve, transcatheter aortic valve replacement, patient discharge, smoking | Circ Cardiovasc Interv | 2026 | 0 |
| Clinical Implications of Cardiac Damage Staging Discrepancies in Patients Undergoing Transcatheter Aortic Valve Implantation. PMID 42468618 — mortality, aortic valve stenosis, ventricular dysfunction, right, cardiology, aortic valve, transcatheter aortic valve replacement | Can J Cardiol | 2026 | 0 |
| Leaflet Modification With the UNICORN Technique: Why CT Planning and TEE Guidance Matter. PMID 42331421 | JACC Cardiovasc Interv | 2026 | 0 |
| Prognostic value of early haemodynamic valve deterioration after TAVI. PMID 42186872 — echocardiography, transcatheter aortic valve replacement | EuroIntervention | 2026 | 0 |
Clinical Studies 14
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| ATLANTIS Protamine Antagonization of heparin with protamine sulfate to reduce all neurologic ischemic and hemorrhagic events after transcatheter aortic valve implantation for aortic stenosis the ATLANTIS Protamine study 2023-504511-32-00 — protamines, constriction, pathologic, aortic valve stenosis, hospital mortality, insurance, heparin, aortic valve, transcatheter aortic valve replacement | Phase 3 | Recruiting | 2025 |
| Personalized CT guided antithrombotic therapy versus lifelong single antiplatelet therapy to reduce thromboembolic and bleeding events in non atrial fibrillation patients after transcatheter aortic valve implantation a pragmatic international multicentre randomized clinical trial (POPular ATLANTIS trial) 2023-504637-42-01 — constriction, pathologic, aortic valve stenosis, hemorrhage, atrial fibrillation, aortic valve, transcatheter aortic valve replacement, therapeutics | Phase 4 | Recruiting | 2023 |
| Anatomic Stenosis Severity as a Prognostic Marker in Patients With Low Flow Low Gradient Aortic Stenosis Undergoing TAVI NCT04914481 — constriction, pathologic, aortic valve stenosis, tomography, aortic valve, transcatheter aortic valve replacement | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map